
|Articles|March 25, 2021
COPD Stakeholder Summit—Individualizing Treatment and Improving Outcomes, Part 2
In part 2 of the COPD Stakeholder Summit, a panel of experts discuss personalized approaches to COPD management and treatment efficacy.
Advertisement
This activity is supported by an educational grant from Boehringer Ingelheim.
Today, we are bringing you part 2 of a 2-part podcast series discussing chronic obstructive pulmonary disease (COPD). In part 2, moderator Neil Minkoff, MD, chief medical officer of Coeus Healthcare, leads a discussion with a panel of experts about personalized approaches to COPD management and treatment efficacy.
Listen above or through one of these podcast services:
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
2
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
3
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
4
FDA Approves First Disease-Modifying Treatment for AxD
5




